$0.6280
0.0427.17%
Last update: Oct 15, 3:59 PM
$0.6300
0.0447.51%
Rein Therapeutics Inc
RNTXNASDAQ
Rein Therapeutics (RNTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.19 | $-0.49 | $-0.23 | $-0.24 |
| Actual | $-0.10 | $-0.19 | $-0.11 | $-0.21 |
| Surprise | +47.4% | +61.2% | +52.2% | +12.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.10 | $-0.13 |
| Revenue | ||
| Consensus | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.10 | $-0.19 | 47.4 % |
| Q1 | May 15, 2026 | $-0.19 | $-0.49 | 61.2 % |
| Q4 | Mar 26, 2026 | $-0.11 | $-0.23 | 52.2 % |
| Q3 | Nov 14, 2025 | $-0.21 | $-0.24 | 12.5 % |
